![Eyal Breitbart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Eyal Breitbart is a Chief Technology Officer at Vidac Pharma Holding Plc.
Dr. Breitbart was previously employed as a Senior Vice President-Research & Operations by Vascular Biogenics Ltd. He received his undergraduate degree from Bar-Ilan University, a graduate degree from Bar-Ilan University and a doctorate degree from Bar-Ilan University.
| Sociétés | Poste | Début |
|---|---|---|
| VIDAC PHARMA HOLDING PLC | Directeur Technique/Scientifique/R&D | 01/06/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| NOTABLE LABS, LTD. | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Bar-Ilan University
 Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Vidac Pharma Holding Plc
 Vidac Pharma Holding Plc BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
